MeSH term
Frequency | Condition_Probility | Comparative Study | 2 | 0.0 |
Humans | 18 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 14 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Base Sequence | 7 | 0.0 |
DNA Primers | 2 | 0.0 |
Fluorescent Antibody Technique | 3 | 0.0 |
Integrin beta4 | 8 | 47.0 |
Microscopy, Electron | 3 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
*Mutation | 5 | 0.0 |
Phenotype | 3 | 0.0 |
Pylorus/*abnormalities | 9 | 100.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Skin/pathology/ultrastructure | 2 | 11.0 |
Adult | 3 | 0.0 |
Epidermolysis Bullosa/*genetics | 2 | 20.0 |
Female | 8 | 0.0 |
*Gene Deletion | 2 | 0.0 |
Homozygote | 3 | 0.0 |
Infant, Newborn | 7 | 0.0 |
Male | 11 | 0.0 |
Pedigree | 6 | 0.0 |
Antigens, CD/*genetics | 7 | 2.0 |
Exons | 2 | 0.0 |
Loss of Heterozygosity | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Infant | 4 | 0.0 |
Integrin alpha6beta4 | 2 | 10.0 |
Integrins/*genetics | 2 | 11.0 |
Middle Aged | 4 | 0.0 |
Exons/genetics | 3 | 0.0 |
*Mutation, Missense | 2 | 0.0 |
Mutation | 2 | 0.0 |
Child | 2 | 0.0 |
Epidermolysis Bullosa, Junctional/*genetics/pathology | 2 | 25.0 |
Syndrome | 3 | 0.0 |
Epidermolysis Bullosa, Junctional/*genetics | 2 | 8.0 |
Integrins/genetics | 3 | 27.0 |
Skin/pathology | 2 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Heterozygote | 3 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Integrin beta4/*genetics | 2 | 100.0 |
